In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.
Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, describes Horizon Europe and scaling up high-impact and breakthrough research & innovation.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.
Michael Foote, Director of Quote Goat, discusses what financial support is available for businesses that aren't eligible for the government's new lockdown grants, including the Self Employed Income Support Scheme.
Karina Malhotra, founder and MD, Acumentice, explores how technology is being used to solve the elective care conundrum and to what extent emerging tech can make a credible difference on the front line.
According to a new study, COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death but it may increase the risk of pre-term birth.
Ritam Gandhi, Founder and Director, Studio Graphene, discusses how and why large businesses are preparing to lead the charge when it comes to digital innovation in 2021.
Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).
The impact of COVID-19 has proven that we cannot let people with lung conditions continue to be forgotten, says Dr Alison Cook, Chair of the Taskforce for Lung Health.
Debbie Sadler, senior associate on the employment team at Blaser Mills Law, discusses whether or not employers are legally entitled to enforce compulsory COVID-19 vaccination on their workers.
Four new research studies looking into Long COVID in the community will receive funding worth £18.5 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
